Kennedy Capital Management, Inc. Lantheus Holdings, Inc. Transaction History

Kennedy Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $549,161 - $769,319	-9,877 Reduced 39.7%	15,000 $930,000
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $1.5 Million - $2.26 Million	24,877 New	24,877 $1.73 Million
Q1 2023 May 15, 2023	SELL	$47.76 - $82.86 $2.51 Million - $4.35 Million	-52,489 Reduced 43.42%	68,390 $5.65 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $663,867 - $1.06 Million	13,615 Added 12.69%	120,879 $6.16 Million
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $336,151 - $472,265	-5,473 Reduced 4.85%	107,264 $7.54 Million
Q2 2022 Aug 10, 2022	BUY	$55.54 - $72.65 $3.79 Million - $4.96 Million	68,211 Added 153.19%	112,737 $7.44 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $168,163 - $392,288	-6,926 Reduced 13.46%	44,526 $2.46 Million
Q4 2021 Feb 14, 2022	SELL	$22.54 - $30.44 $118,109 - $159,505	-5,240 Reduced 9.24%	51,452 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $1.37 Million - $1.62 Million	56,692 New	56,692 $1.46 Million

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.59B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.